Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
about
Risk of Parkinson's disease after tamoxifen treatment.Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells.The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.Estrogen-BDNF interactions: implications for neurodegenerative diseases.Male/Female differences in neuroprotection and neuromodulation of brain dopamineNeurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.Risk factors for Parkinson's disease may differ in men and women: an exploratory study.Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?Estrogen, testosterone, and methamphetamine toxicity.Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.Alzheimer's disease and other neurological disorders.Rapid estrogen signaling in the brain.Elevated estradiol plasma levels in women with restless legs during pregnancyOestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.Reproductive factors and Parkinson's disease risk in Danish women.Membrane-initiated signaling of estrogen related to neuroprotection. "Social networks" are required.N-cadherin is a novel ERα anchor that protects against 6-OHDA damage to dopaminergic cells.GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones.Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice.Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.Effect of oestrogen receptors on brain NMDA receptors of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
P2860
Q33552831-007200F5-3245-4866-BDFF-58B495C2F8E1Q34523361-C914BA05-17DE-4B80-9D28-7C8425338B82Q34784469-6AF1A8CF-A411-4C58-944F-B167721243B7Q35492403-879FFBC1-F53A-4611-BB9C-B602635060BFQ35552497-6B8A1ADD-6C44-46E1-BB90-50EED3F5B9B1Q35690176-293969FE-962F-4AD7-BC2C-214B61CA6F89Q35972056-80D846A1-0233-4D40-B196-489DA3649449Q36102771-47285714-C05C-4A62-BEE5-EE133E6371CDQ36335715-3ACE1BDD-0868-4D2E-BD68-95CB4DEA12A1Q36499640-840C9477-1CF6-486B-84E7-FE4BD9CE7E80Q36653965-0845E809-75D6-4CF6-8AA3-85F48181CB9FQ36854132-9EF01AB6-0CD6-4043-ADE5-DBE7BD4A6F33Q36946824-CF065C79-8B9E-4C19-8CF6-D1BDAA105B80Q37078034-FA6C4F8D-EB56-4182-BA88-B0AC978CD63DQ37083139-59C49AF4-07D2-4D25-9264-52D4724272F5Q37905899-F308800F-6F62-4F1C-A26B-D5A178E91F83Q38205929-30EA329C-B979-45A4-8CA7-0F9659509A75Q38471641-4D332761-2C8D-4CA3-9E11-75C76C072F7FQ39061178-AD41EBD7-DB53-4BB2-89D5-22D390A582CFQ39336234-6B2D33A7-5D35-4B9B-89E9-D68A860170CFQ43635677-18928025-0942-44C3-81B0-DAC9C446230AQ43809101-A3EEC55D-FB1E-47F5-8647-40C3C07A6354Q44126277-4232DD38-2F52-4930-91F7-6F883D927990Q44209545-7528F30D-72FA-4757-9E8B-E6AEEDBB47A7Q46596326-A1526F83-E48A-4F7E-B715-7DB5064AA850Q48482169-36464CC0-2AEB-4604-B6EF-782FDBF940A8
P2860
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
@en
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
@nl
type
label
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
@en
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
@nl
altLabel
Stereospecific prevention by 17?-estradiol of MPTP-induced dopamine depletion in mice
@en
prefLabel
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
@en
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
@nl
P2093
P2860
P1433
P1476
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
@en
P2093
M Grandbois
M Morissette
T Di Paolo
P2860
P304
P356
10.1002/1098-2396(20000915)37:4<245::AID-SYN1>3.0.CO;2-5
P577
2000-09-01T00:00:00Z